Delivery Order SPE2DB22D3501-SPE2DB23FVQ48
Award Date 5/9/23
Potential Completion Date 5/10/23
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Leuprolide 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $39,740.56, and a period of performance through June 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a $24,928.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of 4,564,639,914 units of leuprolide 2-week 14 mg/2.8 ml kits to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Leuprolide 2WK 14 MG/2.8 ML kits, a specialty medication. The contract has a ceiling value of $3,923.83 and an ultimate completion date of October 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a pharmaceutical product, with a firm-fixed price ceiling value of $2,486.30 and a performance period through May 20, 2025. The contract is not set aside and is an open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Leuprolide 2WK 14 MG/2.8 ML Kits. The contract has a ceiling value of $2,295.00 and runs through March 24, 2025. It is a firm fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,065.38, is for the delivery of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The contract has a period of performance ending on March 24, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a for-profit organization and has no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,869.12 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of leuprolide, a specialty injectable medication, to support military treatment programs and facilities. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,651.81, is a delivery order for the supply of Leuprolide 2 Week 14 mg/2.8 ml Kits. The contract has an ultimate completion date of August 22, 2024 and is a Firm Fixed Price contract type. Amerisourcebergen, through its Corporate Office division, will be delivering these critical pharmaceutical products to support military...
- This federal contract award, identified as SPE2DB22D2206|SPE2DB25FGP49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,696.28 delivery order contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant...